A Roll Over Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
-
Cancer -
Tumor -
Neoplasms
For the latest version of this information please go to www.forpatients.roche.com